Michael Ellenbogen - Mar 1, 2022 Form 4/A - Amendment Insider Report for Evolv Technologies Holdings, Inc. (EVLV)

Role: Founder & Chief Innovation Ofc, Director
Signature: /s/ Eric Pyenson, Attorney-in-fact for Michael Ellenbogen
Stock symbol: EVLV
Transactions as of: Mar 1, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 9/15/2022, 08:44 PM
Date Of Original Report: Mar 3, 2022
Previous filing: Sep 28, 2021
Next filing: Sep 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVLV	Stock Option (Right to Buy)	Award	$0	+216K		$0.00	216K	Mar 1, 2022	Class A Common Stock	216K	$3.49	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter.

Remarks:

This amendment is being filed to amend the original Form 4 filed on March 3, 2022 (the "Original Form 4") solely to correct the exercise price in Column 2 of Table II which was inadvertently incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.